AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
Sep 9, 2021
30786_dirs_2021-09-09_6eb56f99-32a5-4eca-a1d8-cf99732fc544.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-07
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-07 | Bio-Rad B Common Stock | M | 3000 | — | Acquired | 301274 | Direct |
| 2021-09-07 | Bio-Rad B Common Stock | F | 1488 | $806.32 | Disposed | 299786 | Direct |
| 2021-09-07 | Bio-Rad B Common Stock | M | 37000 | $100.06 | Acquired | 336786 | Direct |
| 2021-09-07 | Bio-Rad B Common Stock | F | 20660 | $806.32 | Disposed | 316126 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-07 | Restricted Stock Units | $0 | M | 3000 | Disposed | Bio-Rad B Common Stock (3000) | Direct | |
| 2021-09-07 | Non-Qualified Stock Option (right to buy) | $100.06 | M | 37000 | Disposed | 2021-11-04 | Bio-Rad B Common Stock (37000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 12838 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad A Common Stock | 423670 | Direct |
Footnotes
F1: Shares of Class B common stock acquired on the vesting of restricted stock units.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
F5: On September 7, 2016, the reporting person was granted 15,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F6: The option, representing a right to purchase a total of 37,000 shares, became exercisable in five equal annual installments beginning on November 4, 2012, which was the first anniversary of the date on which the option was granted.